For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Mexicali 21200

0 studies enrolling now · 10 studies all time

What they study most

Axial Spondyloarthritis, Osteoporosis, Plaque Psoriasis, Rheumatoid Arthritis, Spondyloarthritis

Studies at this site

• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Study of LY3337641 in Rheumatoid Arthritis — Stopped early
• A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
• A Rheumatoid Arthritis Study in Participants — Completed